About this trial
This study investigates health behaviour and readiness for lifestyle change in patients who recently had a heart attack (myocardical infarction) treated with stenting (PTCA). Despite successful acute treatment, many patients remain at increased risk of a second heart atttack because lifestyle changes are not consistently maintained. Participants who had a heart attack within the past 6 months will complete standardized questionnaires on readiness to change, quality of life, anxiety/depression, and physical functioning, plus a free-text section on personal barriers to change. Findings will characterize this population and inform a future lifestyle intervention trial
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age over 18 years
myocardial infarction within past 6 months
PTCA treatment
Disqualifiers
Age under 18
history of multiple myocardial infactionrs
myocardial infarction more than 6 months prior
myocardial infarction not treated by PTCA
Trial population
Patients from the catchment area of the Westdeutsches Herz- und Gefäßzentrum, University Hospital Essen, treated for acute myocardial infarction with PTCA. Recruitment and eligibility screening take place during the routine post-discharge follow-up visit at the Lipidambulanz, within approx. 3 months. after the index event. creening is performed by the treating physician within the existing doctor-patient relationshop, without recording study-specifix personal data. Eligible patients are approached in person by a stdy physician and enrolled only after written informed consent.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
PIAC (Perception, Intention and Ability to Change) Scale
Readiness and ability to change health-related behavior, habits and living conditions, assessed using the PIAC questionnaire, a validated 9 item instrument covering awareness of negative health behaviors, intention to change and implementation of change strategies. Higher scores indicate a better awareness and intention to change.
Secondary outcomes
SF-36 (Short-form 36 Health Survey)
Health-related quality of life assessed using the SF-36, yielding a physical and a mental summary score; higher scores indicate better quality of life.
HADS (Hospital Anxiety and Depression Scale)
Anxiety and depressive Symptoms assessed using the HADS(-A) for Anxiety and HADS-(D) for depression. each ssubscales ranges from 0-21; higher scores indicate greater severity.
KCCQ-23 (Kansas City Cardiomyopathy Questionnaire)
Disease-specific health status using the KCCQ-23 covering physical limitations, symptoms, self-efficacy, social limitation and quality of life. Scores ranging 0-100 with higher scores indicating better health status.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Kliniken Essen-Mitte
Lead sponsor
Universitätsklinikum Essen
Sponsor institution
Universitätsklinikum Essen
Collaborator
This trial is not recruiting at the moment. You can still explore other options: